Dr. Jason Gaglia, Dr.
Claim this profileJoslin Diabetes Center
Studies Type 1 Diabetes
Studies Insulin Resistance
7 reported clinical trials
8 drugs studied
Area of expertise
1Type 1 Diabetes
HLA positive
GAD65 positive
C peptide
2Insulin Resistance
Affiliated Hospitals
Clinical Trials Jason Gaglia, Dr. is currently running
DIAGNODE-3 study
for recently diagnosed type I diabetes
This trial tests if using Diamyd and Vitamin D can help young people and adults with Type 1 Diabetes. The goal is to help their bodies keep making insulin for longer. High dose vitamin D and omega 3 have shown promise in prolonging remission in Type 1 Diabetes.
Recruiting1 award Phase 32 criteria
Observational Study
for Type 1 Diabetes
This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D). This observational study will: * follow participants to determine how long they continue to produce insulin, and * will also assess how changes in the immune system over time relate to the ability to produce insulin. This information could help design better therapies for type 1 diabetes in the future.
Recruiting1 award N/A2 criteria
More about Jason Gaglia, Dr.
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jason Gaglia, Dr. has experience with
- Placebo
- Ladarixin
- Colecalciferol 2000 IU
- Placebo For Recombinant Human Glutamic Acid Decarboxylase (rhGAD65) Formulated In Alhydrogel®
- Recombinant Human Glutamic Acid Decarboxylase (rhGAD65) Formulated In Alhydrogel®
- NNC0361-0041
Breakdown of trials Jason Gaglia, Dr. has run
Type 1 Diabetes
Insulin Resistance
Impaired Glucose Tolerance
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jason Gaglia, Dr. specialize in?
Jason Gaglia, Dr. focuses on Type 1 Diabetes and Insulin Resistance. In particular, much of their work with Type 1 Diabetes has involved HLA positive patients, or patients who are GAD65 positive.
Is Jason Gaglia, Dr. currently recruiting for clinical trials?
Yes, Jason Gaglia, Dr. is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jason Gaglia, Dr. has studied deeply?
Yes, Jason Gaglia, Dr. has studied treatments such as Placebo, Ladarixin, Colecalciferol 2000 IU.
What is the best way to schedule an appointment with Jason Gaglia, Dr.?
Apply for one of the trials that Jason Gaglia, Dr. is conducting.
What is the office address of Jason Gaglia, Dr.?
The office of Jason Gaglia, Dr. is located at: Joslin Diabetes Center, Boston, Massachusetts 02215 United States. This is the address for their practice at the Joslin Diabetes Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.